CIK 0001894525 · <br>Emerging growth company
Apimeds Pharmaceuticals US, Inc.
Sign in to watch- Ticker
- APUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851099700
- Phone
- 848-201-5010
- Business address
- 100 MATAWAN RD, SUITE 325, MATAWAN, NJ, 07747
- 425 Deal Prospectus/Communication re Business Combination
- 8-K/A Event Executive or director change · Bylaws or fiscal year change · Other events
- NT 10-K Other NT 10-K
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Executive or director change · Bylaws or fiscal year change · Other events
- 8-K Event Executive or director change · Bylaws or fiscal year change · Other events
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Other events
- DEFM14C Other DEFM14C
- 425 Deal Prospectus/Communication re Business Combination
- 8-K/A Event Acquisition or sale completed
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- PREM14C Other PREM14C
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 8-K/A Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Acquisition or sale completed · New debt or obligation · Unregistered share sale · Change in control · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
- 4/A Insider Changes in Ownership
Page 2 of 7 · 130 filings